AI + Digital Maturity in Contract Manufacturing
Exclusive Report

CDMO Periodic Table

Download

CDMO Live Europe 2026 Early Bird

Agenda Download

Days

Hours

Minutes

Seconds

CDMO News

Intravacc Partners With SynphaBase to Support Conjugate Vaccine Development

Cosmos Health Secures Contract Manufacturing Orders for 253,657 Pharmaceutical Units

Cellares Joins NAIA to Advance U.S. Biomanufacturing Capacity

WuXi AppTec Faces Biosecure Act Implications Following U.S. Listing

Cytovance Biologics Launches Cell Line Development Services for Mammalian Programs

Scinai Immunotherapeutics Reports Q1 2026 Results Following Recipharm Israel Deal

Symeres Expands Spray Drying Capabilities at New Jersey CMC Site

Axplora Consolidates UDCA Manufacturing at Vizag Site by End of 2026

Chime Biologics Expands Manufacturing Capacity With New GMP-2 Facility

Chime Biologics Partners With Daewoong Pharmaceutical on Dupilumab Biosimilar

Matica Biotechnology Partners With UHN on IL-10 Adenoviral Gene Therapy Manufacturing

More CDMO News

Cosmos Health Secures Contract Manufacturing Orders for 253,657 Pharmaceutical Units

Cellares Joins NAIA to Advance U.S. Biomanufacturing Capacity

WuXi AppTec Faces Biosecure Act Implications Following U.S. Listing

Cytovance Biologics Launches Cell Line Development Services for Mammalian Programs

Scinai Immunotherapeutics Reports Q1 2026 Results Following Recipharm Israel Deal

Symeres Expands Spray Drying Capabilities at New Jersey CMC Site

Axplora Consolidates UDCA Manufacturing at Vizag Site by End of 2026

Chime Biologics Expands Manufacturing Capacity With New GMP-2 Facility

Chime Biologics Partners With Daewoong Pharmaceutical on Dupilumab Biosimilar

Matica Biotechnology Partners With UHN on IL-10 Adenoviral Gene Therapy Manufacturing

More CDMO News

White Paper[Download]

Why Compliance-Driven CDMOs Win Sponsor Contracts

RESOURCES

CDMO News

CDMO News

Intravacc Partners With SynphaBase to Support Conjugate Vaccine Development

Intravacc Partners With SynphaBase to Support Conjugate Vaccine Development

Cosmos Health Secures Contract Manufacturing Orders for 253,657 Pharmaceutical Units

Cellares Joins NAIA to Advance U.S. Biomanufacturing Capacity

WuXi AppTec Faces Biosecure Act Implications Following U.S. Listing

Cytovance Biologics Launches Cell Line Development Services for Mammalian Programs

Scinai Immunotherapeutics Reports Q1 2026 Results Following Recipharm Israel Deal

Symeres Expands Spray Drying Capabilities at New Jersey CMC Site

Axplora Consolidates UDCA Manufacturing at Vizag Site by End of 2026

Chime Biologics Expands Manufacturing Capacity With New GMP-2 Facility

Chime Biologics Partners With Daewoong Pharmaceutical on Dupilumab Biosimilar

Matica Biotechnology Partners With UHN on IL-10 Adenoviral Gene Therapy Manufacturing

Cosmos Health Secures Contract Manufacturing Orders for 253,657 Pharmaceutical Units

Cellares Joins NAIA to Advance U.S. Biomanufacturing Capacity

WuXi AppTec Faces Biosecure Act Implications Following U.S. Listing

Cytovance Biologics Launches Cell Line Development Services for Mammalian Programs

Scinai Immunotherapeutics Reports Q1 2026 Results Following Recipharm Israel Deal

Symeres Expands Spray Drying Capabilities at New Jersey CMC Site

Axplora Consolidates UDCA Manufacturing at Vizag Site by End of 2026

Chime Biologics Expands Manufacturing Capacity With New GMP-2 Facility

Chime Biologics Partners With Daewoong Pharmaceutical on Dupilumab Biosimilar

Matica Biotechnology Partners With UHN on IL-10 Adenoviral Gene Therapy Manufacturing

Why Compliance-Driven CDMOs Win Sponsor Contracts

Resilience, Risk & Relationships – ExM Leaders Report

[DOWNLOAD] Partnerships for an Uncertain World: The CDMO Live Europe 2026 Report

CDMO Contract Negotiations Timelines Explained

Welcome to PharmaSource

Follow us

Top Links

Get in touch